Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Recruiting
Observational Study
Lung Injury
Cardiopulmonary Bypass
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 12 Months
- Sex
- Any
- Study type
- Observational
- Participants needed
- 56 (estimated)
- Sponsor
- Sophia Koutsogiannaki · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Are \< 12months of age
* Scheduled for cardiac surgical needing CPB
* Preoperative SpO2 \> 90%
Exclusion Criteria:
* Lack of parental (or legal guardian's) consent
* Preoperative SpO2 \< 90%
* Preoperative oxygen therapy
Contacts